Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Propensity-Matched Cohort Study

29.03.2026 | Lishinsky-Fischer N, Gharra S, Nitzan I, Chowers I, Levy J

Am J Ophthalmol. 2026 Apr;284:153-160. doi: 10.1016/j.ajo.2025.12.035

ROGNOSTIC FACTORS FOR DEVELOPMENT OF GLIOSIS AFTER INTERNAL LIMITED MEMBRANE FLAP FOR IDIOPATHIC MACULAR HOLES

29.03.2026 | Barayev E, Krubiner M, Leshchinski T, Tiosano A, Gal-Or O, Nawrocki J, Nawrocka ZA, Ehrlich R

Retina. 2026 Feb 1;46(2):342-350. doi: 10.1097/IAE.0000000000004685

Quantifying Orbital Segmentation in Thyroid Eye Disease- Fat to Muscle Ratio correlates with Restrictive Strabismus

29.03.2026 | Armarnik S, Hilewitz D, Kinori M, Barnea N, Lederer M, Bachar O, Zloto O, Simon GB, Landau-Prat D, Haviv L, Orkin D, Priel A

Am J Ophthalmol. 2026 Mar 20:S0002-9394(26)00140-6. doi: 10.1016/j.ajo.2026.03.018

High Yield of Systemic Workup in Patients with Acute Isolated Paracentral Acute Middle Maculopathy

29.03.2026 | Hostovsky A, Peled I, Katz G, Leshno A, Fogel Levin M

Ophthalmology. 2026 Apr;133(4):499-505. doi: 10.1016/j.ophtha.2025.12.003

Flame-shaped epiretinal membranes: expanding the spectrum beyond neurofibromatosis type 2

29.03.2026 | Fogel Levin M, Hostovsky A, Feo A, Yao M, Santina A, Estawro R, Jung JY, Abraham N, Pineles SL, Sarraf D

Can J Ophthalmol. 2026 Mar 5:S0008-4182(26)00059-1. doi: 10.1016/j.jcjo.2026.02.004

The Natural History of Exophoria Progression Among Young Healthy Adults

19.02.2026 | Armarnik S, Kinori M, Yahalomi T, Kozlov Y, Ekshtein A, Levian L, Kleinmann G, Tehori O

Am J Ophthalmol. 2026 Feb;282:113-119. doi: 10.1016/j.ajo.2025.10.025

Outcome of endoscopic dacryocystorhinostomy in elderly versus younger adults: a comparative analysis

19.02.2026 | Cnaan RB, Wengier A, Bez M, Harash L, Abumanhal M, Neiderman NC, Leibovitch I, Abergel A

Can J Ophthalmol. 2026 Feb 11:S0008-4182(26)00012-8. doi: 10.1016/j.jcjo.2026.01.012

Association between semaglutide use and thyroid eye disease-related outcomes in autoimmune thyroiditis with type II diabetes

19.02.2026 | Shlomov T, Nitzan I, Pollack R, Zloto O, Gur Z

Can J Ophthalmol. 2026 Jan 28:S0008-4182(26)00011-6. doi: 10.1016/j.jcjo.2026.01.010